Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422188 · ClinicalTrials.gov registry record · Phase 1
Deoxycholic Acid Injection for the Treatment of Superficial Lipomas
A Phase 1 study, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00422188 is a Phase 1 study that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 16 participants.
The verdict
NCT00422188, a Phase 1 study, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this research is to compare the safety and effectiveness of 4 different concentrations of deoxycholic acid injection against a placebo in the treatment of superficial lipomas.
Interventions
- DRUG Placebo
- DRUG Deoxycholic Acid Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00422188
The ClinicalTrials.gov registry entry for NCT00422188 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00422188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00422188 about?
NCT00422188 is a clinical study titled "Deoxycholic Acid Injection for the Treatment of Superficial Lipomas". The purpose of this research is to compare the safety and effectiveness of 4 different concentrations of deoxycholic acid injection against a placebo in the treatment of superficial lipomas.
What is the current status of trial NCT00422188?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2007-01. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00422188?
The interventions under investigation include: Placebo (DRUG), Deoxycholic Acid Injection (DRUG).
Who is sponsoring clinical trial NCT00422188?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.